Late-Onset Sepsis and Meningitis Caused by Elizabethkingia meningoseptica: A Case Report Authors: Shasha Liao, Shaoling Qiu, Na Li, Yunyuan Liu, Xiuneng Tang Published: 2026 ABSTRACT AbstractElizabethkingia meningoseptica is a gram-negative bacillus. Increasing body of literature shows that opportunistic infections may be caused by this Gram negative bacillus in immunocompromised adults and neonates. We describe a case of a preterm neonate born at 33 weeks of gestation who presented with fever and reluctance to feed for two days at one month after birth. Initial laboratory tests of blood and cerebrospinal fluid cultures showed evidence of late-onset sepsis and meningitis caused by E. meningoseptica, which was sensitive to piperacillin/tazobactam, cefoperazone/sulbactam, trimethoprim/sulfamethoxazole, levofloxacin, and minocycline. The neonate underwent sequential anti-infective therapy regimens consisting of: 1) cefoperazone/sulbactam (2:1) in combination with levofloxacin; 2) cefoperazone/sulbactam (2:1) paired with rifampicin; and 3) linezolid administered concomitantly with rifampicin. The neonate exhibited clinical manifestations of ventricular dilatation accompanied by hydrocephalus. The neonate received an 85-day course of anti-infective treatment during hospitalization. Follow-up cranial computed tomography (CT) imaging performed four months post-discharge demonstrated complete resolution of the previously observed complications.Keywords: Elizabethkingia meningoseptica, late-onset sepsis, meningitis, preterm neonate, therapy Introduction Elizabethkingia meningoseptica belongs to the Weeksellaceae family of bacteria. It is a gram-negative, nonmotile, and non-spore-forming bacillus. The bacterium is intrinsically resistant to most β - lactam antibiotics, carbapenems, and aminoglycoside antibacterial agents.1,2 It usually causes early-onset sepsis and meningitis in preterm neonates.1–3 E. meningoseptica is frequently multidrug-resistant, posing substantial diagnostic and therapeutic challenges for clinicians. This case report aims to highlight E. meningoseptica as a potential etiologic agent of neonatal late-onset sepsis and to underscore the associated diagnostic and therapeutic challenges. Case Presentation We report a case of a one-month-old female neonate who presented with fever and poor feeding for two days. She was born preterm at 33 weeks’ gestation via cesarean delivery to a 31-year-old primigravida as part of a dichorionic diamniotic twin pregnancy. Her birth weight was 1500 g. Her APGAR scores were 10 at 1, 5, and 10 minutes. The baby was admitted with weak breathing and decreased blood oxygen levels, requiring ventilator-assisted ventilation. A chest X-ray from the external hospital indicated significant pulmonary exudation. An initial diagnosis of severe pneumonia, respiratory failure, and late-onset neonatal sepsis was made. Laboratory tests were prescribed, encompassing a complete blood profile, serum bilirubin assay, serum urea and creatinine assessment, serum electrolyte analysis, and C - reactive protein measurement. The outcomes of these initial laboratory examinations are presented in Table 1. Table 1Baseline Laboratory Parameters of the NeonateParametersValuesHemoglobin (g/dL)91Total leukocyte count (μL)4600Platelets (μL)237,000Hematocrit27.00%Mean corpuscular volume (fL)94.3Mean corpuscular hemoglobin (pg)31.8Lymphocytes25.1%Monocytes10.1%Eosinophils0.3%Bilirubin total (μmol/L)77.23Bilirubin direct (μmol/L)24.13Bilirubin indirect (μmol/L)53.1Urea (mmol/L)2.16Creatinine (μmol/L)22.89Sodium (mmol/L)131Potassium (mmol/L)3.1Chloride (mmol/L)104C-reactive protein (mg/L)173.0Sugar (mmol/L)6.4 Baseline Laboratory Parameters of the Neonate Nil per oral (NPO) was prescribed in conjunction with maintenance intravenous fluids (comprising 0.2% saline, 0.1% potassium, and 5% dextrose water), and the neonate was initiated on empirical intravenous antibiotic treatment (Meropenem at a dosage of 40 mg/kg every 8 hours). Supplemental oxygen inhalation was initiated through nasal prongs owing to the decreasing oxygen saturation. Subsequently, a lumbar puncture was carried out, which obtained a yellow, turbid cerebrospinal fluid (CSF) sample. The results of the CSF analysis strongly indicated bacterial meningitis. The initial findings of the CSF examination are presented in Table 2. Table 2Initial Results of the Cerebrospinal Fluid AnalysisParametersValuesColorLight yellowQuantity (mL)2.5Protein (g/L)2.34Sugar (mmol/L)0.05Leukocytes (μL)6577.00Red blood cellsNonePolymorphs74.4%Lymphocytes25.6% Initial Results of the Cerebrospinal Fluid Analysis Concurrently, two consecutive repeat blood cultures (obtained from two distinct sites) were collected. After 48 hours of incubation, these cultures which were performed by BACTEC/BacTALERT demonstrated the growth of E. meningoseptica. The CSF culture also exhibited comparable growth and sensitivities. The outcomes of the sensitivity patterns are presented in Table 3. Table 3An Elucidation of Sensitivity Patterns to Various Antimicrobial AgentsAntimicrobial AgentSensitivity PatternPiperacillin/tazobactamSensitiveCefoperazone/sulbactamSensitiveTrimethoprim/sulfamethoxazoleSensitiveLevofloxacinSensitiveMinocyclineSensitiveTicarcillin/clavulanateResistantCeftazidimeResistantAztreonamResistantImipenemResistantMeropenemResistantAmikacinResistantGentamicinResistantTobramycinResistantChloramphenicolResistantPiperacillinIntermediateCefepimeIntermediateCiprofloxacinIntermediate An Elucidation of Sensitivity Patterns to Various Antimicrobial Agents After 48 hours of admission, Leukocytes count in CSF of the neonate had increased to 45133/μL. The neonate was promptly administered intravenous cefoperazone/sulbactam (2:1) at a dosage of 240 mg/kg/day, divided into three doses, and levofloxacin at a dosage of 20 mg/kg/day, divided into two doses, at meningitic dosages. The utilization of this antibiotic combination was recommended by the clinical pharmacist. Following the initiation of appropriate antibiotics for a duration of 48 hours, a notable clinical improvement was observed. Breathing improved and the endotracheal tube was removed and replaced with nasal cannula oxygen therapy. A nasogastric tube was placed, followed by a trial of enteral feeding via the tube that was well tolerated by the neonate. Subsequently, nasogastric feeding was progressively and systematically advanced. After a period of 72 hours, febrile episodes ceased completely. Intravenous cefoperazone/sulbactam (2:1) and levofloxacin were maintained for two weeks, resulting in the resolution of all clinical symptoms. Blood and CSF samples obtained one week after antimicrobial initiation were negative. The CSF leukocyte count declined from 45,133/μL to 62/μL. However, on the 23rd day of hospitalization, the CSF examination revealed a leukocytes count of 296/μL, indicating ineffective control of infection. The medical team and clinical pharmacist decided to adjust the anti-infection regimen to cefoperazone/sulbactam (2:1) (240 mg/kg/day in three divided doses) combined with rifampin (20 mg/kg/day in two divided doses). Due to significant ventricular dilation observed on the baby’s cranial MRI (Figure 1), a right ventricular Ommaya reservoir placement was performed on day 44. Subsequent CSF examinations on day 50 and day 56 showed leukocytes count of 89/μL and 99/μL respectively, indicating a decrease but not yet normalization. Following the recommendation of clinical pharmacist, the anti-infection regimen was adjusted to linezolid (30 mg/kg/day in three divided doses) combined with rifampin (20 mg/kg/day in two divided doses) for continued treatment. Cranial MRI images of the acute phase. MRI images (A–F): Increased bilateral temporal pole extracerebral spaces, linear meningeal thickening and enhancement, along with supratentorial ventricular dilatation. After 85 days of anti-infective treatment, the leukocytes count in CSF returned to normal, with negative cultures from both the Ommaya reservoir and ventricular catheter. The neonate was discharged in improved condition. On follow-up cranial CT after treatment, hydrocephalus had cured, with no significant supratentorial ventricular enlargement observed (Figure 2). Cranial CT. Upper panel-CT images of the acute phase (A–D) Cerebral ventricular enlargement is visible, accompanied by interstitial white matter edema in the bilateral frontal lobes. Lower panel-CT images after treatment (E–H) Hydrocephalus had cured, with no significant supratentorial ventricular enlargement observed. Discussion Elizabethkingia spp. have been recognized as emerging pathogens responsible for nosocomial infections and outbreaks, particularly in critical care environments. Correspondingly, these organisms have been isolated from hospital sinks, faucets, and essential medical devices, including endotracheal tubes and bronchial aspirates from mechanically ventilated patients.4 In adults, Elizabethkingia spp. are linked to a broad spectrum of infections, including endocarditis, cellulitis, bronchitis, epididymitis, and abdominal and ocular infections.5 Among pediatric populations, E. meningoseptica infection most commonly manifests as either early-onset sepsis or meningitis, with co-occurrence of both conditions being rarely documented.6 Analysis of the limited available literature on this topic reveals higher mortality and morbidity in neonates relative to infants and older children. Neonates also exhibited the greatest neurological morbidity, with hydrocephalus developing in 30.4% of survivors and some degree of hearing loss in 6.5%.6 The unusual and rare presentation of E. meningoseptica as late-onset sepsis with meningitis distinguishes the present case from other similarly reported cases in the medical literature. Elizabethkingia spp. exhibit intrinsic resistance to multiple antibiotic, including β-lactams, carbapenems, and aminoglycosides. This inherent multidrug-resistant phenotype is attributed to the presence of specialized metallo-β-lactamase (MBL) genes within the genus, which encode distinct β-lactamases and carbapenemases.7 Consequently, infections caused by these pathogens present substantial therapeutic challenges. In the present case, the neonate was initially managed empirically with meropenem for sepsis and meningitis. Nevertheless, antimicrobial susceptibility testing indicated that the clinical isolate was susceptible only to certain β-lactam/β-lactamase inhibitor combinations (piperacillin-tazobactam, cefoperazone-sulbactam), sulfonamides (trimethoprim-sulfamethoxazole), fluoroquinolones (levofloxacin), and tetracyclines (minocycline). Meanwhile, the initial therapeutic efficacy proved suboptimal. The antimicrobial susceptibility profile of Elizabethkingia meningoseptica remains highly variable, leading to inconsistent therapeutic outcomes across reported cases. In this case, prompt identification of E. meningoseptica via early positive blood and CSF cultures enabled timely escalation to combination therapy with intravenous cefoperazone/sulbactam and levofloxacin—resulting in rapid clinical improvement. Notably, cefoperazone/sulbactam demonstrates favorable CSF penetration in the setting of meningeal inflammation, while levofloxacin exhibits well-documented CSF penetration in bacterial meningitis caused by diverse pathogens—including Streptococcus pneumoniae, Listeria monocytogenes, Enterococcus faecalis, Streptococcus milleri, Haemophilus influenzae, Pseudomonas aeruginosa, and Staphylococcus aureus8—supporting its rational use against E. meningoseptica in the context of confirmed or suspected meningitis. Despite normalization of the neonate’s body temperature and oral intake, CSF biochemical parameters—including elevated protein, reduced glucose, and persistent pleocytosis—remained abnormal, and serial neuroimaging revealed progressive hydrocephalus with ventricular dilation. In light of these persistent CSF abnormalities and radiological progression despite prior therapy, the clinical team initiated adjunctive antimicrobial therapy with linezolid and rifampin—agents not represented in the isolate’s in vitro drug susceptibility profile but selected based on their established CNS penetration and emerging clinical evidence against Elizabethkingia meningoseptica. This empiric regimen led to gradual resolution of CSF abnormalities, radiographic stabilization of ventriculomegaly, and full clinical recovery, culminating in uneventful hospital discharge. Vancomycin, linezolid, and rifampin each achieve clinically relevant CSF concentrations in the setting of meningeal inflammation; notably, linezolid and rifampin have demonstrated efficacy in multiple published case reports9–13 involving E. meningoseptica meningitis—even though their primary indications remain Gram-positive infections—underscoring their potential utility as salvage agents for multidrug-resistant E. meningoseptica CNS infections. Preterm birth represents the predominant risk factor for neonatal meningitis caused by Elizabethkingia meningoseptica. Among reported cases, approximately 50% of infected neonates are low-birth-weight infants (<2500 g), with epidemiological data indicating both a rising annual incidence and a mortality rate approaching 57%.14,15 Survivors frequently suffer severe neurological sequelae, including brain abscesses, postinfectious hydrocephalus, sensorineural hearing loss, and global developmental delay. Conclusions Elizabethkingia meningoseptica is a non-fermentative, Gram-negative, obligately aerobic bacillus. It exhibits intrinsic, multidrug resistance—particularly to β-lactams (including extended-spectrum cephalosporins and carbapenems) and aminoglycosides—while demonstrating consistent in vitro susceptibility to select agents traditionally used against Gram-positive pathogens, notably vancomycin, linezolid, and rifampin. Given the pathogen’s unpredictable resistance profile and limited therapeutic options, antimicrobial therapy must be guided by rigorous, clinically validated susceptibility testing; empirical regimens in neonates—especially preterm infants—should prioritize agents with proven cerebrospinal fluid penetration and documented efficacy in E. meningoseptica meningitis. In this vulnerable population, E. meningoseptica infection commonly presents as purulent meningitis and is associated with high treatment failure rates, neuroanatomical complications, and long-term neurodevelopmental impairment. Funding Statement This study received financial support from two research projects: the Guangxi Comprehensive Evaluation Project (No. KYQD‑13), and the Self‑funded Scientific Research Project of Guangxi Zhuang Autonomous Region Health Commission (No. Z‑A20230364). Ethics and Consent Statement The legal guardian of the neonate has provided written informed consent for publication of the case details. An institutional approval was not required for publishing the case details. Disclosure The authors report no conflicts of interest in this work. References